Analysts expect Safeguard Scientifics, Inc. (NYSE:SFE) to report earnings per share (EPS) of ($1.05) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics posted earnings of ($1.07) per share in the same quarter last year, which indicates a positive year-over-year growth rate of 1.9%. The company is expected to issue its next quarterly earnings results on Thursday, March 1st.

According to Zacks, analysts expect that Safeguard Scientifics will report full year earnings of ($4.47) per share for the current year. For the next fiscal year, analysts anticipate that the company will report earnings of ($4.25) per share. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Safeguard Scientifics.

Safeguard Scientifics (NYSE:SFE) last posted its earnings results on Thursday, October 26th. The asset manager reported ($0.91) earnings per share for the quarter, topping the consensus estimate of ($1.11) by $0.20. During the same quarter in the previous year, the company posted ($1.18) earnings per share.

Several equities analysts recently commented on the stock. Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $13.25 price objective on shares of Safeguard Scientifics in a research note on Wednesday. Zacks Investment Research raised shares of Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $16.00 price objective for the company in a research note on Thursday, November 2nd. Finally, ValuEngine cut shares of Safeguard Scientifics from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th.

Safeguard Scientifics (SFE) opened at $11.90 on Thursday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.03 and a current ratio of 1.03. Safeguard Scientifics has a 12 month low of $10.65 and a 12 month high of $14.40.

A number of large investors have recently modified their holdings of SFE. Granahan Investment Management Inc. MA grew its stake in Safeguard Scientifics by 20.8% during the third quarter. Granahan Investment Management Inc. MA now owns 646,492 shares of the asset manager’s stock valued at $8,631,000 after acquiring an additional 111,370 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Safeguard Scientifics by 6.6% during the second quarter. Dimensional Fund Advisors LP now owns 1,147,008 shares of the asset manager’s stock valued at $13,649,000 after acquiring an additional 71,379 shares in the last quarter. New York State Common Retirement Fund grew its stake in Safeguard Scientifics by 70.6% during the second quarter. New York State Common Retirement Fund now owns 141,814 shares of the asset manager’s stock valued at $1,688,000 after acquiring an additional 58,689 shares in the last quarter. Citadel Advisors LLC grew its stake in Safeguard Scientifics by 173.6% during the second quarter. Citadel Advisors LLC now owns 56,118 shares of the asset manager’s stock valued at $668,000 after acquiring an additional 35,609 shares in the last quarter. Finally, State Street Corp grew its stake in Safeguard Scientifics by 7.9% during the second quarter. State Street Corp now owns 383,000 shares of the asset manager’s stock valued at $4,558,000 after acquiring an additional 28,161 shares in the last quarter. 76.29% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “-$1.05 Earnings Per Share Expected for Safeguard Scientifics, Inc. (SFE) This Quarter” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.americanbankingnews.com/2017/12/07/1-05-earnings-per-share-expected-for-safeguard-scientifics-inc-sfe-this-quarter.html.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Get a free copy of the Zacks research report on Safeguard Scientifics (SFE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Safeguard Scientifics (NYSE:SFE)

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.